New decolonization method could lower infection risk in spine surgery

NCT ID NCT06633588

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This pilot study compares a new decolonization regimen using polyhexanide (nasal gel and body foam) to the standard mupirocin and chlorhexidine treatment for reducing Staphylococcus aureus bacteria before elective spine surgery. The trial includes 24 adults who carry Staph bacteria and are scheduled for spine surgery. The goal is to see if the new approach is feasible, tolerable, and effective at lowering bacterial levels to potentially prevent surgical infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
polyhexanide (nasal gel and body foam)
What this could lead to
If effective, this could offer an alternative decolonization method to reduce infection risk before spine surgery.
What could go wrong
This is a small pilot study with only 24 participants, so results may not be conclusive. The new regimen might not work as well as the standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLONIZATION, ASYMPTOMATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Swiss Paraplegic Centre

    Nottwil, Canton of Lucerne, 6207, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.